| 131.4535 1.334 (1.02%) | 06-10 12:05 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 156.83 | 1-year : | 183.18 |
| Resists | First : | 134.27 | Second : | 156.83 |
| Pivot price | 126.26 |
|||
| Supports | First : | 105.74 |
Second : | 88.09 |
| MAs | MA(5) : | 129.08 |
MA(20) : | 118.99 |
| MA(100) : | 100.15 |
MA(250) : | 83.6 |
|
| MACD | MACD : | 9.1  |
Signal : | 9.1 |
| %K %D | K(14,3) : | 86.4 |
D(3) : | 84.3 |
| RSI | RSI(14): 68.1 |
|||
| 52-week | High : | 134.27 | Low : | 40.34 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GH ] has closed below upper band by 25.5%. Bollinger Bands are 10.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 130.55 - 131.28 | 131.28 - 131.95 |
| Low: | 120.89 - 121.82 | 121.82 - 122.67 |
| Close: | 128.72 - 130.12 | 130.12 - 131.4 |
Tue, 09 Jun 2026
Insider Sell: Michael Bell Sells 2,000 Shares of Guardant Health Inc (GH) - GuruFocus
Mon, 08 Jun 2026
Guardant Health co-CEO Helmy Eltoukhy sells $12.6m in stock - Investing.com
Mon, 08 Jun 2026
Guardant Health CFO Michael Bell sells $257,240 in company shares - Investing.com
Mon, 08 Jun 2026
Guardant Health (NASDAQ: GH) co-CEO’s trust sells 100,000 shares in open market - Stock Titan
Mon, 08 Jun 2026
Guardant Health (GH) CFO sells 2,000 shares in open-market trade - Stock Titan
Sat, 06 Jun 2026
Insider Sell: Steve Krognes Sells Shares of Guardant Health Inc (GH) - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 133 (M) |
| Shares Float | 128 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 105.7 (%) |
| Shares Short | 12,930 (K) |
| Shares Short P.Month | 11,640 (K) |
| EPS | -3.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.38 |
| Profit Margin | -40.1 % |
| Operating Margin | -40.3 % |
| Return on Assets (ttm) | -17.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 48.2 % |
| Gross Profit (p.s.) | 5.28 |
| Sales Per Share | 8.14 |
| EBITDA (p.s.) | -3.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -188 (M) |
| Levered Free Cash Flow | -85 (M) |
| PE Ratio | -38.75 |
| PEG Ratio | 0 |
| Price to Book value | -95.47 |
| Price to Sales | 16.17 |
| Price to Cash Flow | -93.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|